Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
101.08%Depreciation and Amortization Margin
VS
Market
Sector
Industry
History
$ 4.03Close
$ 1.96 - $ 4.21 52-Week Range
Ticker Information
Ticker
VTGNCompany Name
VISTAGEN THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQVISTAGEN THERAPEUTICS INC - Depreciation and Amortization Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
VTGN - DepAmor % Historical data
| Date | Depreciation, Amortization & Accretion | Depreciation and Amortization Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 653K | 101.08% | $ 646K |
| 3/31/2025 | $ 635K | 130.66% | $ 486K |
| 12/31/2024 | $ 615.5K | 88.14% | $ 698.3K |
| 9/30/2024 | $ 597.7K | 68.25% | $ 875.7K |
| 6/30/2024 | $ 581K | 59.87% | $ 970.4K |
| 3/31/2024 | $ 568K | 53.38% | $ 1.06M |
| 12/31/2023 | $ 558.6K | 53.59% | $ 1.04M |
| 9/30/2023 | $ 547.6K | 67.56% | $ 810.5K |
| 6/30/2023 | $ 539.9K | 0% | $ -359.7K |
| 3/31/2023 | $ 531.2K | 0% | $ -227.3K |
Key Performance Insights, Last 5 Years
- VISTAGEN THERAPEUTICS INC's latest trailing twelve months (TTM) DepAmor % stands at 30.51%.
- Over the past 5 years, VISTAGEN THERAPEUTICS INC's average DepAmor % has been 55.72%.
- The median DepAmor % for VISTAGEN THERAPEUTICS INC during this period was 56.73%
- VISTAGEN THERAPEUTICS INC reached its highest DepAmor % over the past 5 years at 130.66%.
- The lowest DepAmor % recorded by VISTAGEN THERAPEUTICS INC in the same timeframe 8.78%
VISTAGEN THERAPEUTICS INC's DepAmor % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
DepAmor % Benchmarks
Similar metrics to Revenues:
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation, Amortization & Accretion - [Cash Flow Statement] A component of operating cash flow [NCFO] representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by operations.
Definition of Depreciation and Amortization Margin
[Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].DepAmor / Revenues
(=) DepAmor % DepAmor % for VISTAGEN THERAPEUTICS INC is calculated as follows: DepAmor [ $ 101.9K ] / Revenues [ $ 334K ]
(=) DepAmor % [ 30.51% ] VTGN - Depreciation and Amortization Margin, Last 5 years
8.78%
Minimum
Jun 30, 2021
130.66%
Maximum
Mar 31, 2025
55.72%
Average
56.73%
Median
DepAmor % Benchmark AnalysisMarket
The chart above depicts the distribution of DepAmor % for companies in the Total Stock Market. The average DepAmor % of the companies is 5.85% with a standard deviation of 5.12%.
The following table provides additional summary stats:
DepAmor % in the Market:
| filtered constituents | 3.31K |
|---|---|
| min | -6.41% |
| max | 22.52% |
| average | 5.85% |
| median | 4.22% |
| std | 5.12% |